Please type a search term (at least two characters)
Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer
The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.
Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard. A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.
Paper in journal Nature Physics is featured as one of the editors’ favourites from the journal’s 15- year lifetime more
EMPIR project has improved measurements for the rate at which energy is absorbed by the human body when using smartphones more
Project on factory of the future is building calibration capabilities for advanced, digital-only industrial sensors more
Improving sources of single photons to accelerate quantum technology innovation more
Assessing new MRI technologies using quantitative methods for more accurate clinical diagnoses more